Cano Health (CANO) Stock Forecast & Price Target

Notice: This company has been marked as potentially delisted and may not be actively trading.

Stock Analysis Analyst Forecasts Earnings Headlines Insider Trades Ownership Trends

Cano Health - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Reduce
Based on 3 Analyst Ratings

Based on 3 Wall Street analysts who have issued ratings for Cano Health in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 3 analysts, 1 has given a sell rating, and 2 have given a hold rating for CANO.

Consensus Price Target

$2.28

High Forecast	$3.75
Average Forecast	$2.28
Low Forecast	$0.80

According to the 3 analysts' twelve-month price targets for Cano Health, the average price target is $2.28. The highest price target for CANO is $3.75, while the lowest price target for CANO is $0.80. .

Type	Current Forecast 7/28/23 to 7/27/24	1 Month Ago 6/28/23 to 6/27/24	3 Months Ago 4/29/23 to 4/28/24	1 Year Ago 7/28/22 to 7/28/23
Consensus Rating	Reduce	Reduce	Reduce	Hold
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)	1 Buy rating(s)
Hold	2 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)	7 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$2.28	$2.28	$1.85	$3.09
Forecasted Upside	N/A	-54.39% Downside	-56.41% Downside	21.93% Upside

Get Cano Health Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CANO and its competitors with MarketBeat's FREE daily newsletter.

Ad Stansberry Research

Get out of cash before the Fed's next meeting

"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."

Click here now to watch this exclusive interview

CANO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CANO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Cano Health Stock vs. The Competition

Type	Cano Health	Medical Companies	S&P 500
Consensus Rating Score	1.67	2.72	2.50
Consensus Rating	Reduce	Moderate Buy	Moderate Buy
Predicted Upside		3,123.46% Upside	9.17% Upside
News Sentiment Rating	Neutral News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/17/2023	UBS Group 4 of 5 stars		Reiterated Rating	Neutral ➝ Sell	$12.00 ➝ $3.75	-55.62%
8/11/2023	Jefferies Financial Group 2 of 5 stars		Downgrade	Buy ➝ Hold
8/11/2023	Citigroup 3 of 5 stars		Downgrade	Buy ➝ Neutral	$4.00 ➝ $0.80	-47.54%
5/16/2023	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$1.00	-21.26%
1/5/2023	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Peer Perform
12/13/2022	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Underperform	$1.50	+6.38%
11/28/2022	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$4.00	+136.69%
11/10/2022	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform	$10.00 ➝ $3.00	+35.13%
11/10/2022	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	John Ransom Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
9/7/2022	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold	$7.00	+19.05%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 05:41 AM ET.

CANO Forecast - Frequently Asked Questions

What is Cano Health's forecast for 2024?: According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for Cano Health is $2.28, with a high forecast of $3.75 and a low forecast of $0.80.
Should I buy or sell Cano Health stock right now?: 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cano Health in the last year. There is currently 1 sell rating and 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "reduce" CANO shares.
Does Cano Health's stock price have much downside?: According to analysts, Cano Health's stock has a predicted downside of -54.39% based on their 12-month stock forecasts.
Do Wall Street analysts like Cano Health more than its competitors?: Analysts like Cano Health less than other "medical" companies. The consensus rating for Cano Health is Reduce while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CANO compares to other companies.